Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iradimed Corp (NQ: IRMD )

43.67 -0.27 (-0.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iradimed Corp

< Previous 1 2 3 Next >
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
Trading to commence effective on the market open June 14, 2024 
From iRadimed Corporation
Via GlobeNewswire
IRMD Stock Earnings: iRadimed Beats EPS, Beats Revenue for Q1 2024
IRMD stock results show that iRadimed beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
From iRadimed Corporation
Via GlobeNewswire
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
iRadimed's Earnings Outlook
Via Benzinga
Wednesday Is Your Last Chance To Buy iRadimed Before The Dividend Payout
Via Benzinga
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
From iRadimed Corporation
Via GlobeNewswire
iRadimed's Earnings: A Preview
Via Benzinga
Should you consider NASDAQ:IRMD for quality investing?
Should you consider IRADIMED CORP (NASDAQ:IRMD) for quality investing? 
Via Chartmill
iRadimed: Q1 Earnings Insights
Via Benzinga
iRadimed's Earnings: A Preview
Via Benzinga
Iradimed Notifies Potential Issue With Certain Syringe Adapter Sets During Use
Via Benzinga
Bruker Stock Rising, Near Buy Point; Gets Rating Upgrade
A Relative Strength Rating upgrade for Bruker stock shows improving technical performance. Will it continue? 
Via Investor's Business Daily
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
From iRadimed Corporation
Via GlobeNewswire
iRadimed's Earnings Outlook
Via Benzinga
iRadimed's Return On Capital Employed Insights
Via Benzinga
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
From iRadimed Corporation
Via GlobeNewswire
Caleres, Cloudflare And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower by more than 50 points on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Earnings Scheduled For November 3, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million. 
Via Benzinga
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
From iRadimed Corporation
Via GlobeNewswire
Recap: iRadimed Q3 Earnings
iRadimed (NASDAQ:IRMD) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings iRadimed beat estimated earnings... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.